RNLXY Stock Renalytix (RNLXY, $0.25) was a top quarterly gainer, rising +39.09%. Expect an Uptrend reversal
at Tickeron.com
Loading...
Renalytix (RNLXY, $0.25) was one of top quarterly gainers, jumping +3 to $0.25 per share. A.I.dvisor analyzed 98 stocks in the Services to the Health Industry Industry over the last three months, and discovered that of them (6) charted an Uptrend while of them (3) trended down. A.I.dvisor found 348 similar cases when RNLXY's price went up within three months. In out of those 348 cases, RNLXY's price went down during the following month. Based on these historical data, A.I. thinks the odds of an Uptrend reversal for RNLXY are
RNLXY saw its Stochastic Oscillator peaks and leaves the overbought zone
The Stochastic Oscillator for RNLXY moved out of overbought territory on November 12, 2025. This could be a bearish sign for the stock and investors may want to consider selling or taking a defensive position. A.I.dvisor looked at 43 similar instances where the indicator exited the overbought zone. In of the 43 cases the stock moved lower. This puts the odds of a downward move at .
Technical Analysis (Indicators)
Bearish Trend Analysis
The Momentum Indicator moved below the 0 level on November 11, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on RNLXY as a result. In of 89 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .
RNLXY moved below its 50-day moving average on October 30, 2025 date and that indicates a change from an upward trend to a downward trend.
The 10-day moving average for RNLXY crossed bearishly below the 50-day moving average on November 04, 2025. This indicates that the trend has shifted lower and could be considered a sell signal. In of 11 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .
Following a 3-day decline, the stock is projected to fall further. Considering past instances where RNLXY declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .
Bullish Trend Analysis
The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where RNLXY's RSI Oscillator exited the oversold zone, of 44 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .
The 50-day moving average for RNLXY moved above the 200-day moving average on October 23, 2025. This could be a long-term bullish signal for the stock as the stock shifts to an upward trend.
Following a +1 3-day Advance, the price is estimated to grow further. Considering data from situations where RNLXY advanced for three days, in of 227 cases, the price rose further within the following month. The odds of a continued upward trend are .
RNLXY may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
Fundamental Analysis (Ratings)
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.000) is normal, around the industry mean (20.827). P/E Ratio (0.000) is within average values for comparable stocks, (113.023). RNLXY's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (2.450). RNLXY has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.027). P/S Ratio (9.302) is also within normal values, averaging (68.870).
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. RNLXY’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. RNLXY’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 96, placing this stock worse than average.
Advertisement